Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy-Reference-Cited by-同舟云学术

Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy

Published:2010-04 Issue:7 Volume:105 Page:1000-1010
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Giesing Michael,Suchy Bernhard,Driesel Gerhard,Molitor Dietmar

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.08920.x/fullpdf

Reference40 articles.

1. Power Doppler ultrasonography-dirceted prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations;Takahashi;Urology,2002

2. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves;Catalona;J Urol,1994

3. Prognostic value of serum markers for prostate cancer;Stenman;Scand J Urol Nephrol Suppl,2005

4. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/mL prostate-specific antigen as cutoff;Luboldt;Eur Urol,2001

5. Utility of local anesthesia of the periprostatic plexus in the control of the pain in the ultrasound-guided prostate biopsy;Cervera Deval;Actas Urol Esp,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy;Cancer and Metastasis Reviews;2023-07-13

2. Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers;Frontiers in Immunology;2023-03-15

3. Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer;Biomedicines;2022-12-02

4. Circulating Tumor Microemboli: Characteristics and Clinical Relevance;Atlas of Liquid Biopsy;2021

5. Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer;Cells;2019-07-03